A phase I study of trastuzumab-DM1, a first-in-class HER2 antibody-drug conjugate, in patients with advanced HER2+ breast cancer Meeting Abstract
| Authors: | Krop, I. E.; Beeram, M.; Modi, S.; Rabbee, N.; Girish, S.; Tibbitts, J.; Holden, S. N.; Lutzker, S. G.; Burris, H. A. |
| Abstract Title: | A phase I study of trastuzumab-DM1, a first-in-class HER2 antibody-drug conjugate, in patients with advanced HER2+ breast cancer |
| Meeting Title: | 30th Annual San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Breast Cancer Research and Treatment |
| Volume: | 106 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2007 Dec 13-16 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0167-6806 |
| Publisher: | Springer |
| Date Published: | 2007-12-01 |
| Start Page: | S33 |
| Language: | English |
| ACCESSION: | WOS:000251398500090 |
| PROVIDER: | wos |
| PUBMED: | 17957466 |
| DOI: | 10.1007/s10549-007-9793-3 |
| Notes: | --- - Meeting Abstract: 310 - 30th Annual San Antonio Breast Cancer Symposium - DEC 13-16, 2007 - San Antonio, TX - "1" - "Source: Wos" |
